| Candidate silencer elements for the human and mouse genomes N Doni Jayavelu, A Jajodia, A Mishra, RD Hawkins Nature communications 11 (1), 1061, 2020 | 168 | 2020 |
| Gender specific association of RAS gene polymorphism with essential hypertension: a case‐control study KH Dhanachandra Singh, A Jajodia, H Kaur, R Kukreti, M Karthikeyan BioMed Research International 2014 (1), 538053, 2014 | 92 | 2014 |
| Evidence for schizophrenia susceptibility alleles in the Indian population: an association of neurodevelopmental genes in case–control and familial samples A Jajodia, H Kaur, K Kumari, M Gupta, R Baghel, A Srivastava, M Sood, ... Schizophrenia research 162 (1-3), 112-117, 2015 | 35 | 2015 |
| Diverse facets of COMT: from a plausible predictive marker to a potential drug target for schizophrenia M Gupta, H Kaur, A Jajodia, S Jain, K Satyamoorthy, M Mukerji, J Thirthalli, ... Current Molecular Medicine 11 (9), 732-743, 2011 | 32 | 2011 |
| Evaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations A Jajodia, H Kaur, K Kumari, N Kanojia, M Gupta, R Baghel, M Sood, ... Molecular genetics & genomic medicine 4 (1), 18-27, 2016 | 24 | 2016 |
| Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of … H Kaur, A Jajodia, S Grover, R Baghel, S Jain, R Kukreti American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165 …, 2014 | 24 | 2014 |
| Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients H Kaur, A Jajodia, S Grover, R Baghel, M Gupta, S Jain, R Kukreti PLoS One 9 (7), e102556, 2014 | 20 | 2014 |
| Identifying a predictive model for response to atypical antipsychotic monotherapy treatment in south Indian schizophrenia patients M Gupta, NS Moily, H Kaur, A Jajodia, S Jain, R Kukreti Genomics 102 (2), 131-135, 2013 | 20 | 2013 |
| Genetic studies indicate a potential target 5‐HTR3B for Drug Therapy in Schizophrenia Patients M Gupta, S Jain, NS Moily, H Kaur, A Jajodia, M Purushottam, R Kukreti American Journal of Medical Genetics-Neuropsych Genetics Part B 159 (8), 1006, 2012 | 18 | 2012 |
| Evaluating the Role of Genetic Variants on first‐line antiepileptic drug response in North India: Significance of SCN1A and GABRA1 Gene Variants in Phenytoin … R Baghel, S Grover, H Kaur, A Jajodia, C Rawat, A Srivastava, ... CNS neuroscience & therapeutics 22 (9), 740-757, 2016 | 14 | 2016 |
| Exploring the Carbamazepine Interaction with Human Pregnane X Receptor and Effect on ABCC2 Using in Vitro and in Silico Approach GK Grewal, KD Singh, N Kanojia, C Rawat, S Kukal, A Jajodia, A Singhal, ... Pharmaceutical research 34, 1444-1458, 2017 | 12 | 2017 |
| Synergistic association of STX1A and VAMP2 with cryptogenic epilepsy in North Indian population R Baghel, S Grover, H Kaur, A Jajodia, S Parween, J Sinha, A Srivastava, ... Brain and Behavior 6 (7), e00490, 2016 | 12 | 2016 |
| Candidate silencer elements for the human and mouse genomes. Nat Commun 11: 1061 N Doni Jayavelu, A Jajodia, A Mishra, RD Hawkins | 11 | 2020 |
| Methylation of a HTR3A promoter variant alters the binding of transcription factor CTCF A Jajodia, KD Singh, A Singhal, S Vig, M Datta, Y Singh, M Karthikeyan, ... RSC Advances 5 (57), 45710-45717, 2015 | 9 | 2015 |
| Pharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project data H Kaur, A Jajodia, S Grover, N Agarwal, R Baghel, R Kukreti Pharmacogenomics 15 (12), 1575-1587, 2014 | 6 | 2014 |
| Renin angiotensin system gene polymorphisms in response to antihypertensive drugs and visit-to-visit blood pressure variability in essential hypertensive patients K Dhanachandra Singh, A Jajodia, H Kaur, R Kukreti, M Karthikeyan Current Pharmacogenomics and Personalized Medicine 12 (4), 227-235, 2014 | 4 | 2014 |
| Research Highlights: highlights from the latest articles focusing on a new gene set for better drug response prediction of epilepsy patients R Baghel, A Jajodia, S Grover, R Kukreti Pharmacogenomics 15 (5), 581-586, 2014 | 4 | 2014 |
| An atlas of silencer elements for the human and mouse genomes N Doni Jayavelu, A Jajodia, A Mishra, RD Hawkins bioRxiv, 252304, 2018 | 3 | 2018 |
| Identification of functional enhancer variants associated with type I diabetes in CD4+ T cells A Mishra, A Jajodia, E Weston, ND Jayavelu, M Garcia, D Hossack, ... Frontiers in Immunology 15, 1387253, 2024 | | 2024 |
| Schizophrenia susceptibility and neuregulin signaling pathway genes: A rare haplotype combination based association study in Indian population A Jajodia, H Kaur, A Srivastava, K Kumari, R Baghel, D Guin, M Sood, ... Psychiatry research 262, 628-630, 2018 | | 2018 |
Harpreet KaurCleveland Clinic, Clevealnd Ohio, USE-mailová adresa ověřena na: ccf.org
